CDNA
CareDx Accelerates Growth Strategy with Strategic Portfolio Actions
CareDx, Inc. has announced its first quarter 2026 financial results, marking significant progress in its growth strategy. During an earnings call earlier today, April 28th, President and Chief Executive Officer John Hanna highlighted the company's commitment to transforming into a precision diagnostics market leader. Two key portfolio actions